Comparison of stereotactic body radiotherapy following transcatheter arterial chemoembolization vs transcatheter arterial chemoembolization alone in hepatocellular carcinoma

Table 3 Predictive analysis of recurrence risk: Cox hazard regression findings among study participants

	Univariate			Multivariate
	P value	HR	95%CI of HR	P value	HR	95%CI of HR
Age (years)	0.095	1.02	0.98-1.09	0.372	1.03	0.98-1.08
SBRT (yes)	< 0.001	0.12	0.02-0.28	0.002	0.08	0.02-0.34
Baseline AFP (ng/dL)	0.005	1	1-1.02	0.068	1	1-1.02
Baseline size of lesion (cm)	0.238	0.85	0.57-1.16	0.285	0.83	0.58-1.19
Baseline number of lesions	0.975	1.02	0.50-2.05
Number of affected lobes (bilobular)	0.825	0.92	0.46-1.90
CR after TACE	0.430	0.45	0.05-3.65

CR: Complete response; AFP: Alpha-fetoprotein; SBRT: Stereotactic body radiation therapy; TACE: Transarterial chemoembolization; HR: Hazard ratio.